MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis.
Hanxiao WangYou LiXiting PuXueying LiangRuqi TangXiong MaPublished in: Journal of gastroenterology (2023)
PBC patients carrying the rs661899 T allele are associated with poor prognosis and adverse outcomes after 1-year UDCA therapy.